Correlation Between Inozyme Pharma and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Catalyst Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Catalyst Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inozyme and Catalyst is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Catalyst Pharmaceuticals. In addition to that, Inozyme Pharma is 1.66 times more volatile than Catalyst Pharmaceuticals. It trades about -0.73 of its total potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.06 per unit of volatility. If you would invest 2,186 in Catalyst Pharmaceuticals on August 28, 2024 and sell it today you would lose (67.00) from holding Catalyst Pharmaceuticals or give up 3.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Catalyst Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| Catalyst Pharmaceuticals |
Inozyme Pharma and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Catalyst Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
| Catalyst Pharmaceuticals vs. Eliem Therapeutics | Catalyst Pharmaceuticals vs. HCW Biologics | Catalyst Pharmaceuticals vs. Scpharmaceuticals | Catalyst Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |